Nouvelle déclaration d'incident
No de la demande: 2018-6450
Numéro de référence du titulaire d'homologation: USA-BAYERBAH-2018-US0058569 (Report 525323)
Nom du titulaire (nom légal complet, aucune abbréviation): Bayer inc
Adresse: 2920 Matheson Blvd
Ville: Mississaugua
État: ON
Pays: Canada
Code postal /Zip: L4W 5R6
Incident chez un animal domestique
Pays: UNITED STATES
État: CONNECTICUT
Inconnu
ARLA No d'homologation ARLA No de la demande d'homologation EPA No d'homologation. 11556-155
Nom du produit: Seresto collar
Autre (préciser)
COLLAROui
Autres unités: COLLAR
Site: Animal / Usage sur un animal domestique
Propriétaire de l'animal
Dog / Chien
Terrier (Rat) canine
1
Femme
9
6.35
kg
Cutanée
>1 mo <= 6 mos / > 1 mois < = 6 mois
>1 mo <=2 mos / > 1 mois < = 2 mois
Système
Persisted until death
Oui
Non
Mort
Treatment / Traitement
(p.ex. description des symptômes tels que la fréquence et la gravité
On an unspecified date in Aug2018, the dog developed pacing, panting, and anorexia. On approximately 01Sep2018, the dog was examined by a veterinarian and administered an unspecified amount of subcutaneous fluids. Approximately 4 hours post treatment with the SC fluids, the dog developed twitching, vomited, and died. It is unknown if a necropsy was preformed.
Mort
N - Unlikely - Reported pacing and anorexia are an unspecific signs and may have numerous other causes. Signs may occur initially after collar administration but are not expected to appear after long time. Panting is not expected with product use, however may be consequence of reported pacing. Further reported signs reported after long time to onset and shortly after application of other products. Vomiting is an unspecific sign and may have other causes. Twitching is not anticipated with appropriate topical product administration. No oral product exposure reported. Even with oral product exposure which was not reported only transient gastrointestinal signs but no neurological signs would be expected. Death is not expected either following appropriate topical product application as inconsistent with product's pharmacological profile. Oral exposure to the collar is not expected to cause serious signs either. An overdose of 5 collars around the neck was investigated in adult cats and dogs for an 8 months period and in 10 week old kittens and 7 week old puppies for a 6 months period without causing serious signs. No signs of anaphylaxis reported which would have occurred in close proximity to the collar application. Time to onset long. Role of concomitant medicaments must be considered in this case as dog died shortly after application of these products. Overall, a product relation considered as unlikely.